Quotient Sciences has received a Transatlantic Growth Award at a ceremony hosted by BritishAmerican Business
The award recognizes UK companies that have made significant investments across the Atlantic in the last year. 32 companies, including Quotient Sciences, were recognized.
Quotient Sciences' US investment included the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, PA. The $15 million investment is helping to build a Centre of Excellence for early-phase formulation development and clinical trial manufacturing.
“Our new facility was built in response to increasing customer demand,” said Mark Egerton, CEO of Quotient Sciences. “The site was specifically designed to optimize our ability to work with highly potent and poorly soluble molecules that dominate the industry pipeline. The facility also increases our capacity to provide integrated Translational Pharmaceutics® programs in the U.S., which deliver substantial benefits to customers including cost savings and reduced timelines to achieve proof-of-concept.”
The award was presented to Gordon Cameron, CFO of Quotient Sciences, during a ceremony held in London.